Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: J Breath Res. 2016 Feb 11;10(1):017106. doi: 10.1088/1752-7155/10/1/017106

Table 8.

Classification results from repeated 10-fold cross-validation and repeated double cross-validation on urine samples from patients with bladder cancer and patients with haematuria and or prostatic symptoms. LDA = linear discriminant analysis; and SVM-P = support vector machine; and CI = confidence interval of mean values.

Repeated 10-Fold cross-validation
Accuracy Sensitivity Specificity

Classifier Mean Median CI Mean Median CI Mean Median CI

LDA 96.4 100.0 [94.2-98.3] 92.1 100.0 [90.4-93.6] 97.8 100.0 [95.5-99.5]
SVM-P 97.1 100.0 [95.5-98.8] 88.6 100.0 [82.0-94.7] 100.0 100.0 [99.4-100.0]

Repeated double cross-validation

Accuracy Sensitivity Specificity

Classifier Mean Median CI Mean Median CI Mean Median CI

LDA 93.6 93.8 [92.1-95.1] 87.4 87.5 [84.0-90.5] 95.7 95.8 [94.1-97.1]
SVM-P 96.2 96.9 [95.3-97.2] 87.2 87.5 [83.5-91.0] 99.2 100.0 [98.5-99.8]